Asymmetry Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Asymmetry Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4.88M	Buy	104,755 +47,469	+83%	+$1.58M	2.59%	18
2021 Q3	$1.55M	Sell	57,286 -3,962	-6%	-$104K	0.93%	24
2021 Q2	$1.57M	Sell	61,248 -41,038	-40%	-$978K	1.08%	24
2021 Q1	$3.5M	Sell	102,286 -36,098	-26%	-$1.3M	1.81%	23
2020 Q4	$4.68M	Buy	138,384 +80,633	+140%	+$2.13M	2.13%	18
2020 Q3	$1.43M	Buy	+57,751	New	+$1.55M	0.92%	29

Other funds holding ITOS

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return